세계의 중화 항체 시장 : 항체 유형별, 타겟 바이러스별, 용도별, 최종 사용자별, 판매 채널별, 지역별
Neutralizing Antibody Market, By Antibody Type, By Target Virus, By Application, By End User, By Distribution Channel, By Geography
상품코드
:
1741169
리서치사
:
Coherent Market Insights
발행일
:
2025년 03월
페이지 정보
:
영문
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
세계의 중화 항체 시장은 2025년 2,439억 3,000만 달러로 추정되고, 2032년까지 4,345억 8,000만 달러에 이를 것으로 예측되며, 2025년부터 2032년까지 CAGR 8.6%로 성장할 전망입니다.
| 보고 범위 |
보고서 세부정보 |
| 기준연도 |
2024년 |
2025년 시장 규모 |
2,439억 3,000만 달러 |
| 실적 데이터 |
2020-2024년 |
예측 기간 |
2025-2032년 |
| 예측 기간: 2025-2032년 CAGR: |
8.60% |
2032년 가치 예측 |
4,345억 8,000만 달러 |
중화 항체는 자연 면역의 중요한 구성 요소이며, 자연 감염과 백신 접종 모두에 의해 유도됩니다. 이 항체는 바이러스의 특정 부분을 인식하고 바이러스가 세포에 결합하여 감염하는 것을 저지합니다.
시장 역학:
세계의 중화항체 시장은 예측기간 중에 급성장이 예상됩니다. 또한 mAbs 개발을 위한 첨단 기술의 도입은 이 시장의 성장을 가속할 것으로 예측됩니다.
본 조사의 주요 특징
- 본 보고서에서는 세계의 중화 항체 시장을 상세하게 분석하여 2024년을 기준연도로 한 예측기간 2025-2032년 시장 규모 및 연간 평균 성장률(CAGR%)을 제공합니다.
- 또, 다양한 부문에 걸친 잠재적인 수익 기회를 밝혀, 이 시장의 매력적인 투자 제안 매트릭스에 대해서 해설했습니다.
- 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품의 상시나 승인, 시장 동향, 지역별 전망, 주요 기업이 채용하는 경쟁 전략 등에 관한 중요한 고찰도 제공합니다.
- 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 실적, 전략 등의 파라미터를 바탕으로 세계 중화 항체 시장의 주요 기업 프로파일을 제공합니다.
- 본 보고서로부터 얻을 수 있는 통찰에 의해 마케팅 담당자나 기업의 경영진은 장래의 제품 발매, 유형, 시장 확대, 마케팅 전술에 관한 정보에 근거한 의사 결정을 실시할 수 있습니다.
- 세계의 중화 항체 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 참가자, 재무 분석가 등 이 업계의 다양한 이해관계자를 대상으로 하고 있습니다.
- 이해관계자는 세계 중화 항체 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정이 용이해집니다.
목차
제1장 조사의 목적과 전제조건
제2장 시장 전망
- 보고서 설명
- 주요 요약
- Coherent Opportunity Map(COM)
제3장 시장 역학, 규제, 동향 분석
- 시장 역학
- COVID-19 팬데믹
- 감염증의 만연 증가
- 자가면역질환의 발생률 상승
- 바이오테크놀러지와 단일클론항체 개발 진보
- 영향 분석
- 주요 하이라이트
- 규제 시나리오
- 제품 출시/승인
- PEST 분석
- PORTER 분석
- 합병과 인수 시나리오
제4장 중화 항체 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향
- COVID-19 역학
- 공급측과 수요측의 분석
- 경제에 미치는 영향
제5장 중화 항체 시장 : 항체 유형별, 2020-2025년
제6장 중화 항체 시장 : 타겟 바이러스별, 2020-2025년
- SARS-CoV-2(COVID-19)
- HIV
- 인플루엔자
- 에볼라
- 지카
- C형 간염
- 기타
제7장 중화 항체 시장 : 용도별, 2020-2025년
제8장 중화 항체 시장 : 최종 사용자별, 2020-2025년
- 병원 및 진료소
- 연구기관
- 진단실험실
- 제약회사
- 기타
제9장 중화 항체 시장 : 판매 채널별, 2020-2025년
- 최종 사용자에게 직접 판매
- 리셀러
- 온라인 소매
- 기타
제10장 중화항체 시장 : 지역별, 2020-2025년
- 북미
- 유럽
- 영국
- 독일
- 이탈리아
- 프랑스
- 스페인
- 러시아
- 기타 유럽
- 아시아태평양
- 중국
- 인도
- 일본
- ASEAN
- 호주
- 한국
- 기타 아시아태평양
- 라틴아메리카
- 중동 및 아프리카
- GCC
- 이스라엘
- 북아프리카
- 중앙 아프리카
- 기타 중동 및 아프리카
제11장 경쟁 구도
- Regeneron Pharmaceuticals, Inc.
- Eli Lilly and Company
- AstraZeneca PLC
- GlaxoSmithKline plc
- Sanofi SA
- Roche Holding AG
- Novartis AG
- Merck & Co., Inc.
- Pfizer Inc.
- Johnson & Johnson
- Takeda Pharmaceutical Company Limited
- Moderna, Inc.
- BioNTech SE
- CSL Limited
- Sinovac Biotech Ltd.
제12장 섹션
JHS
영문 목차
Neutralizing Antibody Market is estimated to be valued at USD 243.93 Bn in 2025 and is expected to reach USD 434.58 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8.6% from 2025 to 2032.
| Report Coverage |
Report Details |
| Base Year: |
2024 |
Market Size in 2025: |
USD 243.93 Bn |
| Historical Data for: |
2020 To 2024 |
Forecast Period: |
2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: |
8.60% |
2032 Value Projection: |
USD 434.58 Bn |
Neutralizing antibodies are a critical component of natural immunity and can be induced by both natural infection and vaccination. These antibodies recognize specific parts of the virus and prevent them from binding to and infecting cells. The antibodies' specialized structure allows them to bind to the receptor binding domain (RBD) on the viral spike protein, preventing it from engaging the host cell's receptor and facilitating virus entry into the cell.
Market Dynamics:
The global neutralizing antibody market is expected grow rapidly over the forecast period. One of the key drivers for this growth is the high prevalence of infectious diseases such as hepatitis, HIV, and tuberculosis. The availability of several therapeutic mAbs is another factor driving market growth. In addition, the introduction of advanced technologies for developing mAbs is expected to drive the growth of this market. However, the high cost of these tests can limit their adoption, thereby hindering market growth.
Key features of the study:
- This report provides in-depth analysis of the global neutralizing antibody market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global neutralizing antibody market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Regeneron Pharmaceuticals, Inc., Eli Lilly and Company, AstraZeneca PLC, GlaxoSmithKline plc, Sanofi SA, Roche Holding AG, Novartis AG, Merck & Co., Inc., Pfizer Inc., Johnson & Johnson, Takeda, Pharmaceutical Company Limited, Moderna, Inc., BioNTech SE, CSL Limited, and Sinovac Biotech Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global neutralizing antibody market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global neutralizing antibody market
Neutralizing Antibody Market Detailed Segmentation:
- By Antibody Type:
- Monoclonal Antibodies
- Polyclonal Antibodies
- By Target Virus:
- SARS-CoV-2 (COVID-19)
- HIV
- Influenza
- Ebola
- Zika
- Hepatitis C
- Others
- By Application:
- Therapeutics
- Diagnostics
- Research and Development
- By End User:
- Hospitals and Clinics
- Research Institutes
- Diagnostic Laboratories
- Pharmaceutical Companies
- Others
- By Distribution Channel:
- Direct Sales to End-Users
- Distributors
- Online Retail
- Others
- By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
- Key Players
- Regeneron Pharmaceuticals, Inc.
- Eli Lilly and Company
- AstraZeneca PLC
- GlaxoSmithKline plc
- Sanofi SA
- Roche Holding AG
- Novartis AG
- Merck & Co., Inc.
- Pfizer Inc.
- Johnson & Johnson
- Takeda Pharmaceutical Company Limited
- Moderna, Inc.
- BioNTech SE
- CSL Limited
- Sinovac Biotech Ltd.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Neutralizing Antibody, By Antibody Type
- Market Neutralizing Antibody, By Target Virus
- Market Neutralizing Antibody, By Application
- Market Neutralizing Antibody, By End User
- Market Neutralizing Antibody, By Distribution Channel
- Market Neutralizing Antibody, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- COVID-19 Pandemic
- Increasing Prevalence of Infectious Diseases
- Rising Incidence of Autoimmune Disorders
- Advancements in Biotechnology and Monoclonal Antibody Development
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Neutralizing Antibody Market - Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
5. Neutralizing Antibody Market, By Antibody Type, 2020-2025, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Monoclonal Antibodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2025,(US$ Bn)
- Polyclonal Antibodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2025,(US$ Bn)
6. Neutralizing Antibody Market, By Target Virus, 2020-2025, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- SARS-CoV-2 (COVID-19)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2025,(US$ Billion)
- HIV
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2025,(US$ Billion)
- Influenza
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2025,(US$ Billion)
- Ebola
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2025,(US$ Billion)
- Zika
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2025,(US$ Billion)
- Hepatitis C
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2025,(US$ Billion)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2025,(US$ Billion)
7. Neutralizing Antibody Market, By Application, 2020-2025, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Therapeutics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2025,(US$ Billion)
- Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2025,(US$ Billion)
- Research and Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2025,(US$ Billion)
8. Neutralizing Antibody Market, By End User, 2020-2025, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2025,(US$ Billion)
- Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2025,(US$ Billion)
- Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2025,(US$ Billion)
- Pharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2025,(US$ Billion)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2025,(US$ Billion)
9. Neutralizing Antibody Market, By Distribution Channel, 2020-2025, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Direct Sales to End-Users
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2025,(US$ Billion)
- Distributors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2025,(US$ Billion)
- Online Retail
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2025,(US$ Billion)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2025,(US$ Billion)
10. Neutralizing Antibody Market, By Region, 2020-2025, (US$ Bn)
- Introduction
- Market Share Analysis, By Country, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Country 2021 -2032
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Antibody Type, 2020-2025,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Target Virus, 2020-2025,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2025,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2025,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2025,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2025,(US$ Bn)
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Antibody Type, 2020-2025,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Target Virus, 2020-2025,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2025,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2025,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2025,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2025,(US$ Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Antibody Type, 2020-2025,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Target Virus, 2020-2025,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2025,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2025,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2025,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2025,(US$ Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Antibody Type, 2020-2025,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Target Virus, 2020-2025,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2025,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2025,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2025,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2025,(US$ Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Antibody Type, 2020-2025,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Target Virus, 2020-2025,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2025,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2025,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2025,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2025,(US$ Bn)
- GCC
- Israel
- North Africa
- Central Africa
- Rest of Middle East & Africa
11. Competitive Landscape
- Regeneron Pharmaceuticals, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Eli Lilly and Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- AstraZeneca PLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- GlaxoSmithKline plc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Sanofi SA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Roche Holding AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Takeda Pharmaceutical Company Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Moderna, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- BioNTech SE
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- CSL Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Sinovac Biotech Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
12. Section
- Research Methodology
- About us
관련자료
